BENEDETTI, Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 2.165
EU - Europa 1.053
AS - Asia 167
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.387
Nazione #
US - Stati Uniti d'America 2.160
IE - Irlanda 422
IT - Italia 257
GB - Regno Unito 94
UA - Ucraina 86
DE - Germania 56
SG - Singapore 55
CN - Cina 53
FI - Finlandia 33
GR - Grecia 26
VN - Vietnam 26
SE - Svezia 24
TR - Turchia 19
NL - Olanda 13
HU - Ungheria 12
FR - Francia 11
PK - Pakistan 6
AT - Austria 5
CA - Canada 5
BE - Belgio 4
IN - India 4
PT - Portogallo 4
ES - Italia 3
KR - Corea 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
DK - Danimarca 1
IL - Israele 1
IQ - Iraq 1
MK - Macedonia 1
RS - Serbia 1
Totale 3.387
Città #
Chicago 534
Wilmington 433
Dublin 420
Falls Church 334
Chandler 193
Jacksonville 135
Naples 44
New York 44
Princeton 44
Caserta 43
Roxbury 37
Singapore 37
Boardman 35
Medford 29
Dong Ket 26
Beijing 24
Ann Arbor 16
Cambridge 15
Napoli 14
Bremen 13
Ashburn 11
Houston 11
Stuttgart 11
Aversa 10
Des Moines 10
San Mateo 10
Mountain View 8
Lappeenranta 7
Woodbridge 7
Groningen 6
Rome 6
Boydton 5
London 5
Milan 5
Nanjing 5
Vico Equense 5
Vienna 5
Bacoli 4
Brussels 4
Lisbon 4
Menlo Park 4
Norwalk 4
Villaricca 4
Amsterdam 3
Ariano Irpino 3
Auburn Hills 3
Florence 3
Francolise 3
Helsinki 3
Nocera Inferiore 3
Oulu 3
Ravenna 3
San Giorgio a Cremano 3
Seattle 3
Tianjin 3
Volla 3
Afragola 2
Castellammare Di Stabia 2
Chennai 2
Düsseldorf 2
Elora 2
Ercolano 2
Fairfield 2
Fisciano 2
Hanover 2
Ludwigsburg 2
Madrid 2
Munich 2
Palermo 2
Positano 2
Redwood City 2
Salerno 2
Torre Del Greco 2
Treviso 2
Vancouver 2
Adelaide 1
Avellino 1
Barcelona 1
Bari 1
Basra 1
Bologna 1
Casoria 1
Castenedolo 1
Clearwater 1
Duncan 1
Eboli 1
Gragnano 1
Guangzhou 1
Gujranwala 1
Görwihl 1
Haikou 1
Hangzhou 1
Hebei 1
Jinan 1
Juelsminde 1
Limatola 1
Marcianise 1
Montecorvino Rovella 1
Nijmegen 1
Ningbo 1
Totale 2.723
Nome #
Epigenetic mechanisms underlying prostate cancer radioresistance 1.332
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 86
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 73
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 69
HIF3A inhibition triggers browning of white adipocytes via metabolic rewiring. 67
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 63
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 62
EPIGENETIC-BASED DRUGS IN STEM CELL DIFFERENTIATION 61
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 58
Breast Cancer Vaccines: New Insights 58
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 56
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 53
Epigenetic profiling of the antitumor natural product psammaplin A and its analogues 52
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer 51
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 51
Epigenetic-based therapy: From single- to multi-target approaches 49
Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells 48
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 47
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma 46
Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells. 45
Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients:a meta-analysis of randomized clinical trials 43
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 42
I BET on anti-FGFR to fight cancer resistance 42
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 39
New Anacardic Acid-Inspired Benzamides: Histone Lysine Acetyltransferase Activators 38
Targeting HDACs in diseases: where are we? 37
Modulation of the activity of histone acetyltransferases by long chain alkylidenemalonates (LoCAMs) 37
Structure-Activity Relationships on Cynnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase 37
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer 36
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity 35
Trials with 'epigenetic' drugs: An update. 33
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 33
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 33
Design and synthesis of multifunctional microtubule targeting agents endowed with dual pro-apoptotic and anti-autophagic efficacy 33
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 32
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90 32
The innovative potential of selenium-containing agents for fighting cancer and viral infections 32
Deregulation of new cell death mechanisms in Leukemia 31
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 31
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 31
DNA Mutations via Chern-Simons Currents 28
The pivotal role of miRNA-21 in myocardial metabolic flexibility in response to short- and long-term high glucose treatment: Evidence in human cardiomyocyte cell line 27
Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation. 27
HDAC6 inhibition extinguishes autophagy in cancer: Recent insights 27
Design and Synthesis of New Oligopeptidic Parvulin Inhibitors 27
Interplay between m6 A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives 25
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game? 23
Epigenomic machinery regulating pediatric AML: clonal expansion mechanisms, therapies, and future perspectives 23
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma 23
HAT1: Landscape of Biological Function and Role in Cancer 22
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics 22
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 21
Involvement of regulated cell deaths in aging and age-related pathologies 19
Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome 19
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 18
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 13
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes 13
Harnessing normalcy: The potential of healthy tissuefor patient outcomes 4
Totale 3.515
Categoria #
all - tutte 11.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020159 29 24 0 8 24 1 29 13 14 8 4 5
2020/2021254 17 2 25 20 30 2 35 23 10 22 31 37
2021/20221.169 80 137 253 95 163 42 40 31 27 81 62 158
2022/20231.271 143 110 339 57 68 49 5 41 415 10 13 21
2023/2024442 30 13 16 21 88 65 16 34 11 31 36 81
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 3.515